Reply to “Comment on Morii et al.: Surgical site infection in malignant soft tissue tumors”

We would like to thank the commentators for their interest in our recent publication, “Surgical site infection in malignant soft tissue tumors” [1]. Basically we agree with the comment that the quality of the hospital care control measures for the cases of patients with soft tissue sarcoma undergoing surgery should be re-evaluated and revised. We recognize the significance of the quality of the infection control measures at each hospital. In general, preoperative antibiotic administration before incision, appropriate antibiotic selection, appropriate hair removal and discontinuation of prophylactic antibiotics may be expected to reduce the incidence of surgical site infections [2–4]. Indeed at our institute, at present, most of the recommended measures for the care of patients with soft tissue sarcoma are undertaken.